Literature DB >> 20883728

Oligopeptidase B deficient mutants of Leishmania major.

Jane C Munday1, Karen McLuskey, Elaine Brown, Graham H Coombs, Jeremy C Mottram.   

Abstract

Oligopeptidase B is a clan SC, family S9 serine peptidase found in gram positive bacteria, plants and trypanosomatids. Evidence suggests it is a virulence factor and thus therapeutic target in both Trypanosoma cruzi and T. brucei, but little is known about its function in Leishmania. In this study L. major OPB-deficient mutants (Δopb) were created. These grew normally as promastigotes, had a small deficiency in their ability to undergo differentiation to metacyclic promastigotes, were significantly less able to infect and survive within macrophages in vitro, but were virulent to mice. These data suggest that L. major OPB itself is not an important virulence factor, indicating functional differences between trypanosomes and Leishmania in their interaction with the mammalian host. The possibility that an OPB-like enzyme (designated OPB2) in L. major might compensate for the loss of OPB in Δopb was investigated via by mapping its sequence onto the 1.6Å structure of L. major OPB. This suggested that the residues involved in the S1 and S2 subsites of OPB2 are identical to OPB and hence the substrate specificity would be similar. Consequently there may be redundancy between the two enzymes.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20883728      PMCID: PMC3130898          DOI: 10.1016/j.molbiopara.2010.09.003

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  49 in total

Review 1.  Advances in leishmaniasis.

Authors:  Henry W Murray; Jonathan D Berman; Clive R Davies; Nancy G Saravia
Journal:  Lancet       Date:  2005 Oct 29-Nov 4       Impact factor: 79.321

Review 2.  Autophagosomes: biogenesis from scratch?

Authors:  Fulvio Reggiori; Daniel J Klionsky
Journal:  Curr Opin Cell Biol       Date:  2005-08       Impact factor: 8.382

3.  Expression profiling by whole-genome interspecies microarray hybridization reveals differential gene expression in procyclic promastigotes, lesion-derived amastigotes, and axenic amastigotes in Leishmania mexicana.

Authors:  Timothy R Holzer; W R McMaster; James D Forney
Journal:  Mol Biochem Parasitol       Date:  2006-01-06       Impact factor: 1.759

4.  The involvement of neutrophils in the resistance to Leishmania major infection in susceptible but not in resistant mice.

Authors:  Lin Chen; Zhi-Hui Zhang; Tadashi Watanabe; Takao Yamashita; Takatoshi Kobayakawa; Akira Kaneko; Hiromi Fujiwara; Fujiro Sendo
Journal:  Parasitol Int       Date:  2005-04-12       Impact factor: 2.230

5.  The multiple cpb cysteine proteinase genes of Leishmania mexicana encode isoenzymes that differ in their stage regulation and substrate preferences.

Authors:  J C Mottram; M J Frame; D R Brooks; L Tetley; J E Hutchison; A E Souza; G H Coombs
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

6.  Molecular, functional and structural properties of the prolyl oligopeptidase of Trypanosoma cruzi (POP Tc80), which is required for parasite entry into mammalian cells.

Authors:  Izabela M D Bastos; Philippe Grellier; Natalia F Martins; Gloria Cadavid-Restrepo; Marian R de Souza-Ault; Koen Augustyns; Antonio R L Teixeira; Joseph Schrével; Bernard Maigret; José F da Silveira; Jaime M Santana
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

7.  The genome of the kinetoplastid parasite, Leishmania major.

Authors:  Alasdair C Ivens; Christopher S Peacock; Elizabeth A Worthey; Lee Murphy; Gautam Aggarwal; Matthew Berriman; Ellen Sisk; Marie-Adele Rajandream; Ellen Adlem; Rita Aert; Atashi Anupama; Zina Apostolou; Philip Attipoe; Nathalie Bason; Christopher Bauser; Alfred Beck; Stephen M Beverley; Gabriella Bianchettin; Katja Borzym; Gordana Bothe; Carlo V Bruschi; Matt Collins; Eithon Cadag; Laura Ciarloni; Christine Clayton; Richard M R Coulson; Ann Cronin; Angela K Cruz; Robert M Davies; Javier De Gaudenzi; Deborah E Dobson; Andreas Duesterhoeft; Gholam Fazelina; Nigel Fosker; Alberto Carlos Frasch; Audrey Fraser; Monika Fuchs; Claudia Gabel; Arlette Goble; André Goffeau; David Harris; Christiane Hertz-Fowler; Helmut Hilbert; David Horn; Yiting Huang; Sven Klages; Andrew Knights; Michael Kube; Natasha Larke; Lyudmila Litvin; Angela Lord; Tin Louie; Marco Marra; David Masuy; Keith Matthews; Shulamit Michaeli; Jeremy C Mottram; Silke Müller-Auer; Heather Munden; Siri Nelson; Halina Norbertczak; Karen Oliver; Susan O'neil; Martin Pentony; Thomas M Pohl; Claire Price; Bénédicte Purnelle; Michael A Quail; Ester Rabbinowitsch; Richard Reinhardt; Michael Rieger; Joel Rinta; Johan Robben; Laura Robertson; Jeronimo C Ruiz; Simon Rutter; David Saunders; Melanie Schäfer; Jacquie Schein; David C Schwartz; Kathy Seeger; Amber Seyler; Sarah Sharp; Heesun Shin; Dhileep Sivam; Rob Squares; Steve Squares; Valentina Tosato; Christy Vogt; Guido Volckaert; Rolf Wambutt; Tim Warren; Holger Wedler; John Woodward; Shiguo Zhou; Wolfgang Zimmermann; Deborah F Smith; Jenefer M Blackwell; Kenneth D Stuart; Bart Barrell; Peter J Myler
Journal:  Science       Date:  2005-07-15       Impact factor: 47.728

Review 8.  Leishmaniasis.

Authors:  B L Herwaldt
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

9.  Oligopeptidase B from Trypanosoma evansi. A parasite peptidase that inactivates atrial natriuretic factor in the bloodstream of infected hosts.

Authors:  Rory E Morty; Roger Pellé; István Vadász; Graciela L Uzcanga; Werner Seeger; José Bubis
Journal:  J Biol Chem       Date:  2005-01-11       Impact factor: 5.157

Review 10.  Leishmania species: models of intracellular parasitism.

Authors:  J Alexander; A R Satoskar; D G Russell
Journal:  J Cell Sci       Date:  1999-09       Impact factor: 5.285

View more
  20 in total

1.  Mechanistic insights into mode of actions of novel oligopeptidase B inhibitors for combating leishmaniasis.

Authors:  Sukriti Goyal; Sonam Grover; Jaspreet Kaur Dhanjal; Manisha Goyal; Chetna Tyagi; Sajeev Chacko; Abhinav Grover
Journal:  J Mol Model       Date:  2014-02-25       Impact factor: 1.810

2.  Epoxy-α-lapachone has in vitro and in vivo anti-leishmania (Leishmania) amazonensis effects and inhibits serine proteinase activity in this parasite.

Authors:  Franklin Souza-Silva; Saulo Cabral Bourguignon; Bernardo Acácio Santini Pereira; Luzia Monteiro de Castro Côrtes; Luiz Filipe Gonçalves de Oliveira; Andrea Henriques-Pons; Lea Cysne Finkelstein; Vitor Francisco Ferreira; Paula Fernandes Carneiro; Rosa Teixeira de Pinho; Ernesto Raul Caffarena; Carlos Roberto Alves
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

3.  Genetically attenuated Trypanosoma cruzi parasites as a potential vaccination tool.

Authors:  Cecilia Pérez Brandan; Miguel Ángel Basombrío
Journal:  Bioengineered       Date:  2012-06-18       Impact factor: 3.269

4.  Why strategies to control Leishmania spp. multiplication based on the use of proteinase inhibitors should consider multiple targets and not only a single enzyme.

Authors:  Carlos Roberto Alves; Bernardo Acácio Santini Pereira; Mariana Silva-Almeida; Franklin Souza da Silva
Journal:  J Mol Model       Date:  2014-10-09       Impact factor: 1.810

5.  Proteinases as virulence factors in Leishmania spp. infection in mammals.

Authors:  Mariana Silva-Almeida; Bernardo Acácio Santini Pereira; Michelle Lopes Ribeiro-Guimarães; Carlos Roberto Alves
Journal:  Parasit Vectors       Date:  2012-08-07       Impact factor: 3.876

6.  The Trypanosoma brucei AIR9-like protein is cytoskeleton-associated and is required for nucleus positioning and accurate cleavage furrow placement.

Authors:  Sophie F May; Lori Peacock; Cristina I C Almeida Costa; Wendy C Gibson; Laurence Tetley; Derrick R Robinson; Tansy C Hammarton
Journal:  Mol Microbiol       Date:  2012-03-05       Impact factor: 3.501

7.  The Trypanosoma cruzi virulence factor oligopeptidase B (OPBTc) assembles into an active and stable dimer.

Authors:  Flávia Nader Motta; Izabela M D Bastos; Eric Faudry; Christine Ebel; Meire M Lima; David Neves; Michel Ragno; João Alexandre R G Barbosa; Sônia Maria de Freitas; Jaime Martins Santana
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240

8.  Trypanosoma brucei metacaspase 4 is a pseudopeptidase and a virulence factor.

Authors:  William R Proto; Esther Castanys-Munoz; Alana Black; Laurence Tetley; Catherine X Moss; Luiz Juliano; Graham H Coombs; Jeremy C Mottram
Journal:  J Biol Chem       Date:  2011-09-23       Impact factor: 5.157

9.  Ecotin-like serine peptidase inhibitor ISP1 of Leishmania major plays a role in flagellar pocket dynamics and promastigote differentiation.

Authors:  Lesley S Morrison; Amy Goundry; Marilia S Faria; Laurence Tetley; Sylvain C Eschenlauer; Gareth D Westrop; Anna Dostalova; Petr Volf; Graham H Coombs; Ana Paula C A Lima; Jeremy C Mottram
Journal:  Cell Microbiol       Date:  2012-05-08       Impact factor: 3.715

10.  Trypanosoma brucei BRCA2 acts in a life cycle-specific genome stability process and dictates BRC repeat number-dependent RAD51 subnuclear dynamics.

Authors:  Anna Trenaman; Claire Hartley; Marko Prorocic; Danielle G Passos-Silva; Moniek van den Hoek; Volodymyr Nechyporuk-Zloy; Carlos R Machado; Richard McCulloch
Journal:  Nucleic Acids Res       Date:  2012-12-07       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.